lobbying_activities: 2861522
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2861522 | ddc46822-9684-4379-9370-bb6a158049b9 | Q3 | RED+BLUE STRATEGIES | 400693064 | CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP) | 2022 | third_quarter | MMM | PL 117-169 - The Inflation Reduction Act of 2022 - Support for Medicare-related prescription drug policies including the delay of the Trump-era Medicare Rebate Rule. HR 7666 - The Restoring Hope for Mental Health and Well Being Act of 2022 - Support for policies to improve the nation's mental health system. Senate Finance Committee and HELP Committee initiatives to improve the nation's mental health system. Executive Orders related to ACA improvements. Administration Rules and Regulations focused on Medicare Advantage Administration Policies focused on COVID-19 testing and treatment. PL 117-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, and support for vaccines, testing and telemedicine supports needed during the pandemic. Issues related to increasing access to telehealth and audio-based medicine. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2022-10-08T10:06:58-04:00 |